Ser95

Site Information
DPRVsIystRRPVLA SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 4712797

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 2 , 3 )
Disease tissue studied:	gastric carcinoma, surrounding tissue ( 2 , 3 )
Relevant cell line - cell type - tissue:	stomach ( 2 , 3 )

Downstream Regulation
Effects of modification on Kv7.1:	activity, inhibited ( 1 )

References
1	Gou X, et al. (2018) Protein kinase C epsilon mediates the inhibition of angiotensin II on the slowly activating delayed-rectifier potassium current through channel phosphorylation. J Mol Cell Cardiol 116, 165-174 29452158 Curated Info
2	Ren H (2009) CST Curation Set: 8029; Year: 2009; Biosample/Treatment: tissue, gastrointestinal tract/untreated; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info
3	Ren H (2008) CST Curation Set: 5628; Year: 2008; Biosample/Treatment: tissue, gastrointestinal tract/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info